These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28198505)

  • 1. Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target.
    Zhao HB; Zhang XF; Wang HB; Zhang MZ
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28198505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics.
    Kpetemey M; Chaudhary P; Van Treuren T; Vishwanatha JK
    Oncotarget; 2016 Aug; 7(34):54913-54924. PubMed ID: 27462783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
    Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
    Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR deletion of MIEN1 in breast cancer cells.
    Van Treuren T; Vishwanatha JK
    PLoS One; 2018; 13(10):e0204976. PubMed ID: 30286132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways.
    Li D; Wei Y; Wang D; Gao H; Liu K
    Biochem Biophys Res Commun; 2016 Apr; 472(3):465-70. PubMed ID: 26827826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway.
    Tripathi AK; Desai PP; Tyagi A; Lampe JB; Srivastava Y; Donkor M; Jones HP; Dzyuba SV; Crossley E; Williams NS; Vishwanatha JK
    J Biol Chem; 2024 Mar; 300(3):105680. PubMed ID: 38272230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIEN1 is tightly regulated by SINE Alu methylation in its promoter.
    Rajendiran S; Gibbs LD; Van Treuren T; Klinkebiel DL; Vishwanatha JK
    Oncotarget; 2016 Oct; 7(40):65307-65319. PubMed ID: 27589566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration and Invasion Enhancer 1 Is an NF-ĸB-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In Vivo.
    Chang KS; Tsui KH; Lin YH; Hou CP; Feng TH; Juang HH
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31581708
    [No Abstract]   [Full Text] [Related]  

  • 12. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
    Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
    Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Role of Migration and Invasion Enhancer 1 (MIEN1) in Cancer Progression and Metastasis.
    Kushwaha PP; Gupta S; Singh AK; Kumar S
    Front Oncol; 2019; 9():868. PubMed ID: 31552186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
    J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation.
    Zeng C; Guo J; Wu J; Che T; Huang X; Liu H; Lin Z
    J Biol Chem; 2023 Jun; 299(6):104723. PubMed ID: 37075843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
    Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
    Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
    Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
    Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of C35 in breast carcinomas is associated with tumor progression and lymphnode metastasis.
    Yin K; Ba Z; Li C; Xu C; Zhao G; Zhu S; Yan G
    Biosci Trends; 2015 Dec; 9(6):386-92. PubMed ID: 26781796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MAGE-A11 in breast cancer tissues and its effects on the proliferation of breast cancer cells.
    Xia LP; Xu M; Chen Y; Shao WW
    Mol Med Rep; 2013 Jan; 7(1):254-8. PubMed ID: 23064813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.